Example: Heart Attack

Clinical Trials Sponsored by TetraLogic Pharmaceuticals

Total 12 results

NCT02636244

Unknown status

Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

Conditions: Alopecia Areata
NCT02288208

Terminated

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

Conditions: Hepatitis B
NCT02213861

Unknown status

Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma

Conditions: Cutaneous T-Cell Lymphoma (CTCL)
NCT02147873

Terminated

Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Conditions: Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML)
NCT01940172

Completed

Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Conditions: Relapsed Epithelial Ovarian Cancer; Relapsed Primary Peritoneal Cancer; Relapsed Fallopian Tube Cancer
NCT01828346

Completed

Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy

Conditions: Myelodysplastic Syndrome
NCT01646567

Completed

SHP-141C in Plaque Type Psoriasis

Conditions: Plaque Type Psoriasis
NCT01433731

Completed

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Conditions: Lymphoma, T-Cell, Cutaneous
NCT01188499

Completed

Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors

Conditions: Cancer
NCT00993239

Completed

Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma

Conditions: Cancer
NCT01573780

Terminated

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT02756130

Withdrawn

Birinapant and Carboplatin in Treating Patients With Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions: High Grade Fallopian Tube Serous Adenocarcinoma; High Grade Ovarian Serous Adenocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma